SEARCH RESULTS FOR: "Tag: sldb"
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2019(3)
2018(1)
CATEGORIES
Analyst Update(2)
Buzz Stocks(2)
Intraday Option Activity(1)
Stocks On the Move(1)

8/19/2019 3:17 PM
The shares of gene therapy name Solid Biosciences Inc (NASDAQ:SLDB) hit a five-month high today, after an upgrade from SVB Leerink to "outperform" from "market perform." The brokerage firm also hiked...
5/14/2019 1:35 PM
Stocks are moving sharply higher this afternoon, attempting a rebound while keeping an eye on the latest tweets from President Donald Trump. Three names maintaining investor focus today are drug conc...
2/7/2019 9:19 AM
Solid Biosciences Inc (NASDAQ:SLDB) could be on track for its worst day ever, after the life sciences company reported disappointing preliminary data for its Duchenne Muscular Dystrophy (DMD) gene the...
3/15/2018 10:03 AM
Shares of Solid Biosciences Inc (NASDAQ:SLDB) began trading publicly back on Jan. 26, opening at $25.50, well above their initial public offering (IPO) price of $16. And while SLDB stock went on to h...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center